MissionIR Articles

Capstone Turbine Corporation (NASDAQ: CPST) is the world’s leading developer and manufacturer of clean-and-green microturbine power generation systems, and was first to market with its high efficiency air bearing turbine technology. Capstone has shipped thousands…

Capstone Therapeutics Corp. (OTC: CAPS) is a biotechnology company committed to developing a pipeline of novel peptides and other molecules aimed at helping patients with underserved medical conditions. Its primary asset is ownership in a…

Capricor Therapeutics, Inc. (NASDAQ: CAPR)is focused on discovering, developing and marketing first-in-class therapeutics for the treatment of diseases. Presently, the company is positioned at the forefront of one of the largest segments of the U.S.…

Capnia, Inc. (NASDAQ: CAPN) develops diagnostic and therapeutic products based on its proprietary technology for the precision metering of gas flow. Operating primarily in the U.S., the company offers CoSense for the diagnosis of excessive…

Can-FiteBioPharma Ltd. (NYSE: CANF) is an Israeli biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities. The company has an advanced pipeline of proprietary compounds in phase II and III clinical development stage,…

Founded more than 25 years ago, Cadiz Inc. (NASDAQ: CDZI) is a Los Angeles-based renewable resource company dedicated to pursuing sustainable projects through the responsible stewardship of its land and water resources. The company owns…

Brainstorm Cell Therapeutics, Inc. (NASDAQ: BCLI)is developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases, e.g. Amyotrophic Lateral Sclerosis (ALS a.k.a. Lou Gehrig’s disease), Multiple Sclerosis (MS) and Parkinson’s disease (PD). NurOwn is…

BioTime, Inc. (NYSE: BTX) is building a dominant company in the field of regenerative medicine. The company’s strategy is to be the leader in the development of pluripotent stem cell-based technologies and to apply those…

Biota Pharmaceuticals, Inc. (NASDAQ: BOTA) is focused on discovering and developing direct-acting antivirals to treat infections that affect a significant number of patients globally. The company has four product candidates with limited therapeutic options in…

BioSpecifics Technologies Corp. (NASDAQ: BSTC) is a profitable, commercial-stage biopharmaceutical company that has developed injectable collagenase for 12 clinical indications to date. Injectable collagenase is approved for marketing as XIAFLEX (collagenase clostridium histolyticum or CCH)…

Through its patented platform technologies, BioPharmX Corporation (NYSE MKT: BPMX) develops unique health and wellness products for licensing and commercialization in pharmaceutical, over-the-counter and supplemental use. The BioPharmX team aims to touch lives by providing…

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), an innovative biopharmaceutical company, is developing a universal flu vaccine designed to provide multi-season and multi-strain protection against most human influenza virus strains, including both seasonal and pandemic flu strains.…

BioMark Diagnostics, Inc. (OTCQB: BMKDF) is an oncology-focused company on a mission to develop and market cutting-edge technologies to increase prediction and accuracy in the diagnosis of cancers. The company develops metabolomics-based diagnostic assays for…

Israel-based BioLineRx Ltd. (NASDAQ: BLRX) is a clinical-stage biopharmaceutical company committed to identifying, in-licensing and developing promising therapeutic candidates. The company in-licenses novel compounds primarily from academic institutions and biotech companies based in Israel, develops…

BioLife Solutions, Inc. (NASDAQ: BLFS) is located in Bothell, Washington, on a high-tech campus that has roots as a dairy farm. The company manufactures and markets proprietary protein-free, serum-free cGMP biopreservation media for cells, tissues…

Biocept, Inc. (NASDAQ: BIOC) is developing innovative diagnostic solutions that give patients and doctors the information they need—all from a simple blood test known as a liquid biopsy. Biocept has now developed a unique, patented…

Bio-Path Holdings, Inc. (NASDAQ: BPTH) is focused on developing therapeutic products that use its proprietary liposomal delivery technology, which is designed to systemically distribute nucleic acid drugs throughout the human body via a simple intravenous…

Bio Blast Pharma Ltd. (NASDAQ: ORPN) is a clinical-stage biotechnology company committed to developing clinically meaningful therapies for patients with rare and ultra-rare genetic diseases. Established in 2012, the company is quickly building a diverse…

Bellerophon Therapeutics LLC (NASDAQ: BLPH)is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. Its mission is to develop well-studied molecules deployed…